Urological cancers

Kaiku Health digital therapeutics platform automates the follow-up of patient-reported outcome measures (PROMs) in all urological cancers and integrates seamlessly with other hospital information systems (e.g. SOAP and REST protocols with HL7, XML and JSON messages). Intelligent algorithms screen symptoms, alert care team and provide personalised support for patients. Kaiku Health has built-in modules for prostate cancer, bladder cancer, testicular cancer and kidney cancer. As an ICHOM technology affiliate (International Consortium for Health Outcomes Measurement ) we provide our customers with a wide set of detailed standard sets for gathering Patient-Reported Outcomes.

Advanced prostate cancer

Kaiku Health is compliant with all treatment options available for advanced prostate cancer.

  • Hormonal therapy
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Radionuclide therapy

Enhanced symptom tracking through web-based system can bring a metastatic prostate cancer patient the survival benefit of 5,2 months (Basch et. al, 2017).

Localized prostate cancer

Automated PSA follow-up

Kaiku Health can be integrated to the hospital’s laboratory system in order to automate the delivery of PSA results for patients. Automated PSA follow-up includes following features:

  • Managing PSA risk levels of individual patients
  • SMS reminders for patients to take PSA tests
  • Automated delivery of PSA results within risk limits via SMS – directly to patient’s phone
  • In case PSA levels exceed the risk limits, clinical staff is alarmed
  • Dashboard to follow the progress of PSA results

Kaiku Health follows the RTOG-ASTRO Phoenix definition

Get in touch

Interested in learning more about Kaiku Health? Send us a note.
This form collects your name and email for communication purposes. Check out our privacy policy for further info on how we protect and manage your submitted data.